Experimental studies with curcumin were carried out in human breast cancer cell lines, which expressed p185neu, the oncoprotein encoded by ErbB2/Neu gene. In vitro studies showed that p185neu autophosphorylation and transphosphorylation were inhibited by curcumin. This evidence concerns the gene ERBB2 and breast carcinoma.